Biotechnology UltraSector ProFund, Investor
Biotechnology UltraSector ProFund, Investor (BIPIX)
This fund's primary objective is to generate daily investment returns that are one and a half times (1.5x) the daily movement of the Dow Jones U.S. BiotechnologySM Index, before any deductions for fees and expenses. To achieve this leveraged daily exposure, the fund strategically allocates its assets to various financial instruments that the adviser expects will produce results aligned with its specific investment goal. The aforementioned index serves as a benchmark, monitoring the performance of select companies within the biotechnology sector of the American stock market. It is important to note that this fund is not diversified, indicating a concentrated investment strategy.
BIPIX Mutual Fund Chart & Stats
- Previous Close
- $87.57
- Sub-Category
- Sector-Specific
- Total Liabilities
- $101.76M
- Last Dividend Ex-Date
- Dec 30, 2025
- Expense Ratio
- 1.52%
- Holding Count
- 149
- Brand
- Profunds
- Dividend Yield
- (0.28%)
- Category
- Equity
- Total Assets
- 220.45M
- Shares Outstanding
- N/A
- 52-Week Range
- $59.52 - $105.85
BIPIX Mutual Fund News
BIPIX Mutual Fund Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| USD_CASHAGPXX | 2.40% |
| APGEAPOGEE THERAPEUTICS INC | 1.29% |
| ORKAOruka Therapeutics, Inc. | 1.20% |
| DNTHDianthus Therapeutics, Inc. | 1.12% |
| ERASErasca, Inc. | 1.08% |
| TWSTTwist Bioscience | 1.08% |
| KYMRKymera Therapeutics, Inc. | 1.05% |
| SYRESpyre Therapeutics, Inc | 1.04% |
| RVMDRevolution Medicines, Inc. | 1.04% |
| CGONCG Oncology, Inc. | 1.03% |
| Total | 12.34% |
Recently Viewed
No data currently available






